Rapid Therapeutic Science Laboratories, Inc.

OTCPK:RTSL Stock Report

Market Cap: US$94.9k

Rapid Therapeutic Science Laboratories Past Earnings Performance

Past criteria checks 2/6

Rapid Therapeutic Science Laboratories's earnings have been declining at an average annual rate of -4.4%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 5.8% per year.

Key information

-4.4%

Earnings growth rate

88.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-5.8%
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Jun 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Rapid Therapeutic Science Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:RTSL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 230010
31 Mar 230010
31 Dec 220-210
30 Sep 220-320
30 Jun 220-320
31 Mar 220-420
31 Dec 210-320
30 Sep 210-220
30 Jun 210-320
31 Mar 210-330
31 Dec 200-220
30 Sep 200-220
30 Jun 200-110
31 Mar 200-100
31 Dec 190000
30 Sep 190000
30 Jun 190000
31 Mar 190000
31 Dec 180-300
30 Sep 180-300
30 Jun 180-300
31 Mar 180-300
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150000
30 Jun 150000
31 Mar 150000
31 Dec 140000
30 Sep 140000
30 Jun 140000

Quality Earnings: RTSL has a high level of non-cash earnings.

Growing Profit Margin: RTSL became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RTSL has become profitable over the past 5 years, growing earnings by -4.4% per year.

Accelerating Growth: RTSL has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: RTSL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: RTSL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.